Boc-L-3-Bromophenylalanine
- $285 - $660
- Product name: Boc-L-3-Bromophenylalanine
- CAS: 82278-95-3
- MF: C14H18BrNO4
- MW: 344.2
- EINECS:
- MDL Number:MFCD01317710
- Synonyms:3-Bromo-N-[(1,1-dimethylethoxy)carbonyl]-DL-phenylalanine;3-Bromo-N-[(tert-butoxy)carbonyl]phenylalanine;DL-Phenylalanine, 3-broMo-N-[(1,1-diMethylethoxy)carbonyl]-;N-Boc-3-broMo-DL-phenylalanine, 97%;3-Bromo-N-[(1,1-dimethylethoxy)carbonyl]phenylalanine;3-(3-bromophenyl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid;Boc-L-3-Bromophenylalanine USP/EP/BP;3-Bromophe
3 prices
Selected condition:
Brand
- Acrotein
- Chemenu
- Crysdot
Package
- 5g
- 25g
- ManufacturerAcrotein
- Product numberA-7814
- Product descriptionN-Boc-3-bromo-DL-phenylalanine 97%
- Packaging25g
- Price$660
- Updated2021-12-16
- Buy
- ManufacturerChemenu
- Product numberCM220344
- Product description3-(3-Bromophenyl)-2-((tert-butoxycarbonyl)amino)propanoicacid 95%
- Packaging5g
- Price$285
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD21002385
- Product description3-(3-Bromophenyl)-2-((tert-butoxycarbonyl)amino)propanoicacid 95+%
- Packaging5g
- Price$302
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Acrotein | A-7814 | N-Boc-3-bromo-DL-phenylalanine 97% | 25g | $660 | 2021-12-16 | Buy |
Chemenu | CM220344 | 3-(3-Bromophenyl)-2-((tert-butoxycarbonyl)amino)propanoicacid 95% | 5g | $285 | 2021-12-16 | Buy |
Crysdot | CD21002385 | 3-(3-Bromophenyl)-2-((tert-butoxycarbonyl)amino)propanoicacid 95+% | 5g | $302 | 2021-12-16 | Buy |
Properties
Boiling point :475.3±40.0 °C(Predicted)
Density :1.405
pka :3.81±0.10(Predicted)
Density :1.405
pka :3.81±0.10(Predicted)
Safety Information
Symbol(GHS): | ||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Warning | |||||||||||||||||||||||||||||||||||
Hazard statements: |
|
|||||||||||||||||||||||||||||||||||
Precautionary statements: |
|